Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Májek O[au]:

Colorectal cancer screening: 20 years of development and recent progress. Zavoral M et al. World J Gastroenterol. (2014)

[Editorial]. Dušek L et al. Klin Onkol. (2014)

How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia? Suchanek S et al. World J Gastroenterol. (2016)

Search results

Items: 1 to 50 of 52

1.

Evaluation of the personalized invitation of Czech citizens to screening programs.

Ngo O, Chloupková R, Ambrožová M, Suchánek Š, Zavoral M, Seifert B, Dvořák V, Daneš J, Skovajsová M, Dušek L, Májek O.

Cas Lek Cesk. 2019 Summer;158(3-4):147-150.

PMID:
31416323
2.

Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study.

Ponti A, Ronco G, Lynge E, Tomatis M, Anttila A, Ascunce N, Broeders M, Bulliard JL, Castellano I, Fitzpatrick P, Frigerio A, Hofvind S, Májek O, Segnan N, Taplin S; ICSN DCIS Working Group.

Breast Cancer Res Treat. 2019 Oct;177(3):761-765. doi: 10.1007/s10549-019-05333-6. Epub 2019 Jun 28.

PMID:
31250357
3.

Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years.

Vuik FE, Nieuwenburg SA, Bardou M, Lansdorp-Vogelaar I, Dinis-Ribeiro M, Bento MJ, Zadnik V, Pellisé M, Esteban L, Kaminski MF, Suchanek S, Ngo O, Májek O, Leja M, Kuipers EJ, Spaander MC.

Gut. 2019 Oct;68(10):1820-1826. doi: 10.1136/gutjnl-2018-317592. Epub 2019 May 16.

4.

The detection of DNA methylation of tumour suppressor genes in cervical high-grade squamous intraepithelial lesion: A prospective cytological-histological correlation study of 70 cases.

Ondič O, Němcová J, Alaghehbandan R, Černá K, Gomolčáková B, Kinkorová-Luňáčková I, Chytra J, Šidlová H, Májek O, Bouda J.

Cytopathology. 2019 Jul;30(4):426-431. doi: 10.1111/cyt.12718.

PMID:
31074057
5.

Carcinoma of the uterine cervix in Czech Republic and possibilities of its prevence.

Luňáčková IK, Májek O.

Cesk Patol. Fall 2018;63(4):164-168.

PMID:
30497267
6.

The legal framework for European cervical cancer screening programmes.

Májek O, Anttila A, Arbyn M, van Veen EB, Engesæter B, Lönnberg S.

Eur J Public Health. 2019 Apr 1;29(2):345-350. doi: 10.1093/eurpub/cky200.

PMID:
30265313
7.

Second cancers in Hodgkin's lymphoma long-term survivals: A 60-year single institutional experience with real-life cohort of 871 patients.

Petrakova K, Vyskocil J, Grell P, Majek O, Soumarova R, Novak J, Burkon P, Kral Z, Kazda T, Vyzula R.

Int J Clin Pract. 2018 Jul 16:e13235. doi: 10.1111/ijcp.13235. [Epub ahead of print]

PMID:
30011112
8.

How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia?

Suchanek S, Grega T, Ngo O, Vojtechova G, Majek O, Minarikova P, Brogyuk N, Bunganic B, Seifert B, Dusek L, Zavoral M.

World J Gastroenterol. 2016 Sep 28;22(36):8103-11. doi: 10.3748/wjg.v22.i36.8103. Review.

9.

Performance indicators in a newly established organized cervical screening programme: registry-based analysis in the Czech Republic.

Májek O, Dušková J, Dvořák V, Beková A, Klimeš D, Blaha M, Anttila A, Dušek L.

Eur J Cancer Prev. 2017 May;26(3):232-239. doi: 10.1097/CEJ.0000000000000236.

PMID:
26908155
10.

[Population colorectal cancer screening in the Czech Republic].

Zavoral M, Vojtěchová G, Májek O, Ngo O, Grega T, Seifert B, Dušek L, Suchánek Š.

Cas Lek Cesk. 2016;155(1):7-12. Czech.

PMID:
26898786
11.

[The populations attitudes to colorectal cancer screening in the Czech Republic].

Král N, Seifert B, Suchánek Š, Zavoral M, Májek O.

Epidemiol Mikrobiol Imunol. 2015 Mar;64(1):41-6. Czech.

PMID:
25872995
12.

Estimating cancer incidence, prevalence, and the number of cancer patients treated with antitumor therapy in 2015 and 2020 -  analysis of the Czech National Cancer Registry.

Dusek L, Pavlík T, Májek O, Büchler T, Muzik J, Maluskova D, Koptíková J, Bortlicek Z, Abrahámová J.

Klin Onkol. 2015;28(1):30-43.

PMID:
25692753
13.

[Editorial].

Dušek L, Májek O.

Klin Onkol. 2014;27 Suppl 2:3. No abstract available.

PMID:
25629123
14.

Oncological outcomes of nerve-sparing radical hysterectomy for cervical cancer: a systematic review.

Basaran D, Dusek L, Majek O, Cibula D.

Ann Surg Oncol. 2015 Sep;22(9):3033-40. doi: 10.1245/s10434-015-4377-7. Epub 2015 Jan 23. Review.

PMID:
25613389
15.

[New European Information and Communication Platform Striving for Improved Care for Colorectal Cancer Patients - www.crcprevention.eu].

Dušek L, Poc P, Májek O, Suchánek S, Seifert B, Gregor J, Zavoral M.

Klin Onkol. 2014;27 Suppl 2:131-7. Czech.

PMID:
25494899
16.

[Role and importance of civil society organisations in the support of cancer screening].

Gregor J, Májek O, Dušek L, Snajdrová L.

Klin Onkol. 2014;27 Suppl 2:128-30. Review. Czech.

PMID:
25494898
17.

[National web portals as an official communication platform of cancer screening programmes].

Gregor J, Dušek L, Májek O, Snajdrová L.

Klin Onkol. 2014;27 Suppl 2:124-7. Czech.

PMID:
25494897
18.

[Implementation of performance indicators in the Czech Breast Cancer Screening Programme -  results of the regular monitoring].

Májek O, Bartoňková H, Daneš J, Skovajsová M, Dušek L.

Klin Onkol. 2014;27 Suppl 2:113-23. Czech.

PMID:
25494896
19.

[Performance indicators in screening programmes].

Májek O, Ngo O, Daneš J, Zavoral M, Dvořák V, Klimeš D, Dušek L.

Klin Onkol. 2014;27 Suppl 2:106-12. Review. Czech.

PMID:
25494895
20.

[Results of the Czech National Colorectal Cancer Screening Programme - colonoscopy examinations].

Suchánek S, Májek O, Zavoral M, Seifert B, Ngo O, Dušek L.

Klin Onkol. 2014;27 Suppl 2:98-105. Czech.

PMID:
25494894
21.

[Results of the Czech National Colorectal Cancer screening programme -  faecal occult blood tests].

Seifert B, Májek O, Zavoral M, Král N, Suchánek S, Ngo O, Dušek L.

Klin Onkol. 2014;27 Suppl 2:87-97. Czech.

PMID:
25494893
22.

[Results of the Czech National Cervical Cancer screening programme].

Dušková J, Beková A, Dvořák V, Májek O, Dušek L.

Klin Onkol. 2014;27 Suppl 2:79-86. Czech.

PMID:
25494892
23.

[Results of the Czech National Breast Cancer screening programme].

Skovajsová M, Májek O, Daneš J, Bartoňková H, Ngo O, Dušek L.

Klin Onkol. 2014;27 Suppl 2:69-78. Czech.

PMID:
25494891
24.

[Approach to population-based screening in the Czech Republic, methodology and first results of the personalised invitation of citizens to cancer screening programmes].

Dušek L, Májek O, Bláha M, Daneš J, Zavoral M, Seifert B, Dvořák V, Skovajsová M, Suchánek S, Jung T, Brzková M, Klika P, Klimeš D, Koptíková J, Gregor J.

Klin Onkol. 2014;27 Suppl 2:59-68. Czech.

PMID:
25494890
25.

[State and development of background information for the evaluation of Czech cancer screening programmes].

Dušek L, Májek O, Klimeš D, Bláha M, Brabec P, Gregor J.

Klin Onkol. 2014;27 Suppl 2:49-58. Czech.

PMID:
25494889
26.

[Epidemiology of screening-targeted cancers according to new data of the Czech National Cancer Registry].

Dušek L, Mužík J, Malúšková D, Májek O, Pavlík T, Koptíková J, Gregor J, Brabec P, Abrahámová J.

Klin Onkol. 2014;27 Suppl 2:19-39. Czech.

PMID:
25494887
27.

[Objective need for cancer prevention in the Czech Republic and Europe, and the state thereof].

Dušek L, Májek O, Mužík J, Pavlík T, Koptíková J, Gregor J.

Klin Onkol. 2014;27 Suppl 2:7-18. Czech.

PMID:
25494886
28.

Cancer incidence and mortality in the Czech Republic.

Dusek L, Muzik J, Maluskova D, Májek O, Pavlík T, Koptíková J, Melichar B, Büchler T, Fínek J, Cibula D, Babjuk M, Svoboda M, Vyzula R, Ryska A, Ryska M, Petera J, Abrahámová J.

Klin Onkol. 2014;27(6):406-23.

PMID:
25493580
29.

Prognostic value of scores based on malnutrition or systemic inflammatory response in patients with metastatic or recurrent gastric cancer.

Sachlova M, Majek O, Tucek S.

Nutr Cancer. 2014;66(8):1362-70. doi: 10.1080/01635581.2014.956261. Epub 2014 Oct 30.

PMID:
25356861
30.

International variation in management of screen-detected ductal carcinoma in situ of the breast.

Ponti A, Lynge E, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Mano MP, Kawai M, Scharpantgen A, Fracheboud J, Hofvind S, Vidal C, Ascunce N, Salas D, Bulliard JL, Segnan N, Kerlikowske K, Taplin S; ICSN DCIS Working group.

Eur J Cancer. 2014 Oct;50(15):2695-704. doi: 10.1016/j.ejca.2014.07.019. Epub 2014 Aug 19.

31.

Colorectal cancer screening: 20 years of development and recent progress.

Zavoral M, Suchanek S, Majek O, Fric P, Minarikova P, Minarik M, Seifert B, Dusek L.

World J Gastroenterol. 2014 Apr 14;20(14):3825-34. doi: 10.3748/wjg.v20.i14.3825. Review.

32.

[On the importance of standardization in the assessment of population-based cancer patient survival in the Czech Republic -  methodology and results from the Czech National Cancer Registry].

Uher M, Pavlík T, Májek O, Mužík J, Büchler T, Abrahámová J, Vyzula R, Fínek J, Vorlíček J, Dušek L.

Klin Onkol. 2014;27(2):127-35. Czech.

PMID:
24739049
33.

Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry.

Slavicek L, Pavlik T, Tomasek J, Bortlicek Z, Buchler T, Melichar B, Vyzula R, Prausova J, Finek J, Majek O, Dusek L.

BMC Gastroenterol. 2014 Mar 25;14:53. doi: 10.1186/1471-230X-14-53.

34.

Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000-2008.

Pavlík T, Májek O, Büchler T, Vyzula R, Petera J, Ryska M, Ryška A, Cibula D, Babjuk M, Abrahámová J, Vorlíček J, Mužík J, Dušek L.

Cancer Epidemiol. 2014 Feb;38(1):28-34. doi: 10.1016/j.canep.2013.11.002. Epub 2013 Dec 7.

PMID:
24315848
35.

HPV typing of high-grade dysplasia (CIN III) in cone biopsies of 38 HPV-vaccinated women.

Ondič O, Kašpírková J, Májek O, Kinkorová I.

Virchows Arch. 2014 Jan;464(1):79-83. doi: 10.1007/s00428-013-1511-4. Epub 2013 Nov 26.

PMID:
24276406
36.

Colorectal cancer prevention in the Czech Republic: time trends in performance indicators and current situation after 10 years of screening.

Suchanek S, Majek O, Vojtechova G, Minarikova P, Rotnaglova B, Seifert B, Minarik M, Kozeny P, Dusek L, Zavoral M.

Eur J Cancer Prev. 2014 Jan;23(1):18-26. doi: 10.1097/CEJ.0b013e328364f203.

PMID:
24129196
37.

Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.

Lynge E, Ponti A, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Frigerio A, Kawai M, Scharpantgen A, Broeders M, Hofvind S, Vidal C, Ederra M, Salas D, Bulliard JL, Tomatis M, Kerlikowske K, Taplin S; ICSN DCIS Working group.

Eur J Cancer. 2014 Jan;50(1):185-92. doi: 10.1016/j.ejca.2013.08.013. Epub 2013 Sep 13.

38.

Sex differences in colorectal cancer survival: population-based analysis of 164,996 colorectal cancer patients in Germany.

Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, Nennecke A, Eberle A, Brenner H; GEKID Cancer Survival Working Group.

PLoS One. 2013 Jul 5;8(7):e68077. doi: 10.1371/journal.pone.0068077. Print 2013.

39.

Mammographic screening programmes in Europe: organization, coverage and participation.

Giordano L, von Karsa L, Tomatis M, Majek O, de Wolf C, Lancucki L, Hofvind S, Nyström L, Segnan N, Ponti A; Eunice Working Group, Van Hal G, Martens P, Májek O, Danes J, von Euler-Chelpin M, Aasmaa A, Anttila A, Becker N, Péntek Z, Budai A, Mádai S, Fitzpatrick P, Mooney T, Zappa M, Ventura L, Scharpantgen A, Hofvind S, Seroczynski P, Morais A, Rodrigues V, Bento MJ, Gomes de Carvalho J, Natal C, Prieto M, Sánchez-Contador Escudero C, Zubizarreta Alberti R, Fernández Llanes SB, Ascunce N, Ederra Sanza M, Sarriugarte Irigoien G, Salas Trejo D, Ibáñez Cabanell J, Wiege M, Ohlsson G, Törnberg S, Korzeniewska M, de Wolf C, Fracheboud J, Patnick J J, Lancucki L, Ducarroz S, Suonio E.

J Med Screen. 2012;19 Suppl 1:72-82.

PMID:
22972813
40.

False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes.

Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, Giordano L, Frigerio A, Törnberg S; EUNICE Project and Euroscreen Working Groups, Van Hal G, Martens P, Májek O, Danes J, von Euler-Chelpin M, Aasmaa A, Anttila A, Becker N, Péntek Z, Budai A, Mádai S, Fitzpatrick P, Mooney T, Zappa M, Ventura L, Scharpantgen A, Hofvind S, Seroczynski P, Morais A, Rodrigues V, Bento MJ, Gomes de Carvalho J, Natal C, Prieto M, Sánchez-Contador Escudero C, Zubizarreta Alberti R, Fernández Llanes SB, Ascunce N, Ederra Sanza M, Sarriugarte Irigoien G, Salas Trejo D, Ibáñez Cabanell J, Wiege M, Ohlsson G, Törnberg S, Korzeniewska M, de Wolf C, Fracheboud J, Patnick J, Lancucki L, Ducarroz S, Suonio E.

J Med Screen. 2012;19 Suppl 1:57-66. Review.

PMID:
22972811
41.

[Colorectal carcinoma].

Dusek L, Muzík J, Májek O, Pavlík T.

Rozhl Chir. 2012 Jan;91(1):39-43. Czech. No abstract available.

PMID:
22746077
42.

Survival from colorectal cancer in Germany in the early 21st century.

Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, Nennecke A, Eberle A, Brenner H; GEKID Cancer Survival Working Group.

Br J Cancer. 2012 May 22;106(11):1875-80. doi: 10.1038/bjc.2012.189. Epub 2012 May 3.

43.
44.

Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry.

Pavlík T, Májek O, Mužík J, Koptíková J, Slavíček L, Fínek J, Feltl D, Vyzula R, Dušek L.

BMC Public Health. 2012 Feb 10;12:117. doi: 10.1186/1471-2458-12-117.

45.

Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis.

Cibula D, Zikan M, Dusek L, Majek O.

Expert Rev Anticancer Ther. 2011 Aug;11(8):1197-207. doi: 10.1586/era.11.38.

PMID:
21916573
46.

Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme.

Majek O, Danes J, Skovajsova M, Bartonkova H, Buresova L, Klimes D, Brabec P, Kozeny P, Dusek L.

BMC Public Health. 2011 May 10;11:288. doi: 10.1186/1471-2458-11-288.

47.

Increasing incidence of Geomyces destructans fungus in bats from the Czech Republic and Slovakia.

Martínková N, Bačkor P, Bartonička T, Blažková P, Cervený J, Falteisek L, Gaisler J, Hanzal V, Horáček D, Hubálek Z, Jahelková H, Kolařík M, Korytár L, Kubátová A, Lehotská B, Lehotský R, Lučan RK, Májek O, Matějů J, Rehák Z, Šafář J, Tájek P, Tkadlec E, Uhrin M, Wagner J, Weinfurtová D, Zima J, Zukal J, Horáček I.

PLoS One. 2010 Nov 5;5(11):e13853. doi: 10.1371/journal.pone.0013853.

48.

Czech National Cancer Screening Programmes in 2010.

Májek O, Danes J, Zavoral M, Dvorák V, Suchánek S, Seifert B, Kozený P, Pánová S, Dusek L.

Klin Onkol. 2010;23(5):343-53.

PMID:
21058528
49.

Skin cancer incidence in renal transplant recipients - a single center study.

Kalinova L, Majek O, Stehlik D, Krejci K, Bachleda P.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010 Sep;154(3):257-60.

50.

Tubal ligation and the risk of ovarian cancer: review and meta-analysis.

Cibula D, Widschwendter M, Májek O, Dusek L.

Hum Reprod Update. 2011 Jan-Feb;17(1):55-67. doi: 10.1093/humupd/dmq030. Epub 2010 Jul 15. Review.

PMID:
20634209

Supplemental Content

Support Center